Header Logo

Connection

CHRISTINE NGUYEN to Cost-Benefit Analysis

Back to Details
This is a "connection" page, showing publications CHRISTINE NGUYEN has written about Cost-Benefit Analysis.
CHRISTINE NGUYEN
Connection Strength
0.085
Cost-Benefit Analysis
  1. Cost utility of tumour necrosis factor-a inhibitors for rheumatoid arthritis: an application of Bayesian methods for evidence synthesis in a Markov model. Pharmacoeconomics. 2012 Jul 01; 30(7):575-93.
    View in: PubMed
    Score: 0.085
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.